(Q30734509)

26 June 2017

Laser-induced drusen reduction improves visual function at 1 year. Choroidal Neovascularization Prevention Trial Research Group (English)

1 reference

26 June 2017

1 reference

1 reference

Ho AC

1

1 reference

26 June 2017

Maguire MG

2

1 reference

26 June 2017

Yoken J

3

1 reference

26 June 2017

Lee MS

4

1 reference

26 June 2017

Shin DS

5

1 reference

26 June 2017

Javornik NB

6

1 reference

26 June 2017

Fine SL

7

1 reference

26 June 2017

1 July 1999

1 reference

26 June 2017

1 reference

26 June 2017

106

1 reference

26 June 2017

7

1 reference

26 June 2017

1367-73; discussion 1374

1 reference

Drusen and Disciform Macular Detachment and Degeneration

26 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2900735-6

7 January 2021

Foveal drusen resorption one year after perifoveal laser photocoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2900735-6

7 January 2021

Effects of argon (green) laser treatment of soft drusen in early age-related maculopathy: a 6 month prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2900735-6

7 January 2021

Prophylactic perifoveal laser treatment of soft drusen

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2900735-6

7 January 2021

A pilot randomized controlled study on the effect of laser photocoagulation of confluent soft macular drusen

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2900735-6

7 January 2021

Laser treatment in subjects with high-risk clinical features of age-related macular degeneration. Posterior pole appearance and retinal function.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2900735-6

7 January 2021

Choroidal neovascularization in the Choroidal Neovascularization Prevention Trial. The Choroidal Neovascularization Prevention Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2900735-6

7 January 2021

An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2900735-6

7 January 2021

Longitudinal data analysis for discrete and continuous outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2900735-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2900735-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2900735-6

7 January 2021

Characteristics of Drusen and Bruch's membrane in postmortem eyes with age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2900735-6

7 January 2021

The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2900735-6

7 January 2021

Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2900735-6

7 January 2021

The pathogenesis of tears of the retinal pigment epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2900735-6

7 January 2021

Cellular mechanisms of resolution of drusen after laser coagulation. An experimental study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2900735-6

7 January 2021

A case of visual acuity loss following laser photocoagulation for macular drusen

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2900735-6

7 January 2021

Contrast sensitivity in age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2900735-6

7 January 2021

A model of the incidence and consequences of choroidal neovascularization secondary to age-related macular degeneration. Comparative effects of current treatment and potential prophylaxis on visual outcomes in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2900735-6

7 January 2021

10.1016/S0161-6420(99)00735-6

Identifiers

DOI

1 reference

26 June 2017

1 reference